"Sarcopenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
Descriptor ID |
D055948
|
MeSH Number(s) |
C10.597.613.612.500 C23.300.070.500.500 C23.888.592.608.612.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sarcopenia".
Below are MeSH descriptors whose meaning is more specific than "Sarcopenia".
This graph shows the total number of publications written about "Sarcopenia" by people in this website by year, and whether "Sarcopenia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 0 | 1 |
2012 | 2 | 1 | 3 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2017 | 2 | 0 | 2 |
2018 | 2 | 0 | 2 |
2019 | 3 | 0 | 3 |
2020 | 3 | 0 | 3 |
2021 | 3 | 0 | 3 |
2022 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcopenia" by people in Profiles.
-
Obesity as a premature aging phenotype - implications for sarcopenic obesity. Geroscience. 2022 06; 44(3):1393-1405.
-
Using frequency to bolus-dose resistance training for brief pre-operative windows in geriatric abdominopelvic cancers prehabilitation. J Geriatr Oncol. 2022 06; 13(5):747-753.
-
Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia. Aging Cell. 2022 03; 21(3):e13569.
-
Percentile-based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels. J Cachexia Sarcopenia Muscle. 2022 02; 13(1):190-202.
-
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia. J Cachexia Sarcopenia Muscle. 2021 12; 12(6):1582-1596.
-
Associations of Skeletal Muscle With Symptom Burden and Clinical Outcomes in Hospitalized Patients With Advanced Cancer. J Natl Compr Canc Netw. 2021 01 29; 19(3):319-327.
-
Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia. Sci Rep. 2020 08 18; 10(1):13968.
-
Sarcopenia in urologic oncology: Identification and strategies to improve patient outcomes. Urol Oncol. 2022 Nov; 40(11):474-480.
-
Molecular changes in transcription and metabolic pathways underlying muscle atrophy in the CuZnSOD null mouse model of sarcopenia. Geroscience. 2020 08; 42(4):1101-1118.
-
The High Precision of Functional and Neuromuscular Measures to Classify Sarcopenia in Older Women. J Geriatr Phys Ther. 2019 Oct/Dec; 42(4):E55-E61.